Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Long-Term Debt Repayments (2018 - 2020)

Historic Long-Term Debt Repayments for Neurogene (NGNE) over the last 3 years, with Q1 2020 value amounting to $2000.0.

  • Neurogene's Long-Term Debt Repayments changed 0.0% to $2000.0 in Q1 2020 from the same period last year, while for Mar 2020 it was $9000.0, marking a year-over-year decrease of 7000.0%. This contributed to the annual value of $9000.0 for FY2019, which is 7187.5% down from last year.
  • Per Neurogene's latest filing, its Long-Term Debt Repayments stood at $2000.0 for Q1 2020, which was down 0.0% from $2000.0 recorded in Q4 2019.
  • Over the past 5 years, Neurogene's Long-Term Debt Repayments peaked at $22000.0 during Q3 2018, and registered a low of $2000.0 during Q4 2018.
  • For the 3-year period, Neurogene's Long-Term Debt Repayments averaged around $4777.8, with its median value being $2000.0 (2018).
  • The largest annual percentage gain for Neurogene's Long-Term Debt Repayments in the last 5 years was 0.0% (2019), contrasted with its biggest fall of 8636.36% (2019).
  • Neurogene's Long-Term Debt Repayments (Quarter) stood at $2000.0 in 2018, then changed by 0.0% to $2000.0 in 2019, then changed by 0.0% to $2000.0 in 2020.
  • Its Long-Term Debt Repayments stands at $2000.0 for Q1 2020, versus $2000.0 for Q4 2019 and $3000.0 for Q3 2019.